Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-05-27 @ 8:06 PM
Study NCT ID:
NCT01027351
Status:
COMPLETED
Last Update Posted:
2018-10-09
First Post:
2009-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine
Sponsor:
Novartis Vaccines
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
V72P6E1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None